SKYRIZI (risankizumab-rzaa) is now approved for patients six years of age and older with moderate-to-severe plaque psoriasis or active psoriatic arthritisApproval includes a new 55 mg pre-filled syringe to support weight-based dosing for those patients weighing less than 40 kgSKYRIZI…
A fatal single-vehicle crash early Monday on southbound Interstate 35E at Camp Wisdom Road left the driver dead, sent a passenger to the hospital, and completely closed all southbound lanes....
